OBJECTIVE: To assess the impact of a long-term comprehensive control program for sexually transmitted infections (STIs) in remote Aboriginal communities in Central Australia, and to investigate a recent rise in gonorrhoea prevalence. DESIGN: STI prevalence was determined from annual, cross-sectional, population-wide, age-based screening, 1996-2006. During 2006, gonococcal isolates were obtained by on-site culture and tested for antimicrobial susceptibility. SETTING: Six remote clinics on the Anangu Pitjantjatjara Yankunytjatjara (APY) Lands, South Australia, which are served by Nganampa Health Council, an Aboriginal community-controlled health service. PARTICIPANTS: All resident Aboriginal people aged 14-40 years at the commencement date of each annual population-wide screen. MAIN OUTCOME MEASURES: Multivariable logistic regression models were used to compare prevalence of chlamydial infection, gonorrhoea and syphilis measured during each annual population-wide screen; antimicrobial susceptibility of gonococcal isolates obtained in 2006. RESULTS: Between 1996 and 2003, there was a significant reduction in prevalence of gonorrhoea and chlamydial infection, by 67% and 58%, respectively. Subsequently, chlamydia prevalence rate plateaued, but there was a rapid rise in prevalence of gonorrhoea. Syphilis prevalence decreased linearly over the study period (odds ratio, 0.81; P < 0.001). During the first 6 months of 2006, 89 gonococcal isolates were obtained, 39 through on-site culture during the 6-week screening period, and all were sensitive to penicillin (in the less-sensitive category). CONCLUSIONS: The decrease in STI prevalence associated with the program was maintained until 2006 for chlamydial infection and syphilis, but not for gonorrhoea, which rose in prevalence after 2003. There was no change in antimicrobial resistance to explain this rise, and gonorrhoea transmission dynamics and travel of core transmitters to regions without STI control programs might be responsible.
OBJECTIVE: To assess the impact of a long-term comprehensive control program for sexually transmitted infections (STIs) in remote Aboriginal communities in Central Australia, and to investigate a recent rise in gonorrhoea prevalence. DESIGN: STI prevalence was determined from annual, cross-sectional, population-wide, age-based screening, 1996-2006. During 2006, gonococcal isolates were obtained by on-site culture and tested for antimicrobial susceptibility. SETTING: Six remote clinics on the Anangu Pitjantjatjara Yankunytjatjara (APY) Lands, South Australia, which are served by Nganampa Health Council, an Aboriginal community-controlled health service. PARTICIPANTS: All resident Aboriginal people aged 14-40 years at the commencement date of each annual population-wide screen. MAIN OUTCOME MEASURES: Multivariable logistic regression models were used to compare prevalence of chlamydial infection, gonorrhoea and syphilis measured during each annual population-wide screen; antimicrobial susceptibility of gonococcal isolates obtained in 2006. RESULTS: Between 1996 and 2003, there was a significant reduction in prevalence of gonorrhoea and chlamydial infection, by 67% and 58%, respectively. Subsequently, chlamydia prevalence rate plateaued, but there was a rapid rise in prevalence of gonorrhoea. Syphilis prevalence decreased linearly over the study period (odds ratio, 0.81; P < 0.001). During the first 6 months of 2006, 89 gonococcal isolates were obtained, 39 through on-site culture during the 6-week screening period, and all were sensitive to penicillin (in the less-sensitive category). CONCLUSIONS: The decrease in STI prevalence associated with the program was maintained until 2006 for chlamydial infection and syphilis, but not for gonorrhoea, which rose in prevalence after 2003. There was no change in antimicrobial resistance to explain this rise, and gonorrhoea transmission dynamics and travel of core transmitters to regions without STI control programs might be responsible.
Authors: L Natoli; R J Guy; M Shephard; D Whiley; S N Tabrizi; J Ward; D G Regan; S G Badman; D A Anderson; J Kaldor; L Maher Journal: BMJ Open Date: 2015-04-28 Impact factor: 2.692
Authors: James Ward; Skye McGregor; Rebecca J Guy; Alice R Rumbold; Linda Garton; Bronwyn J Silver; Debbie Taylor-Thomson; Belinda Hengel; Janet Knox; Amalie Dyda; Matthew G Law; Handan Wand; Basil Donovan; Christopher K Fairley; Steven Skov; Donna Ah Chee; John Boffa; David Glance; Robyn McDermott; Lisa Maher; John M Kaldor Journal: BMC Infect Dis Date: 2013-09-09 Impact factor: 3.090
Authors: James Ward; Jane Goller; Hammad Ali; Anna Bowring; Sophia Couzos; Mark Saunders; Phyllis Yau; John M Kaldor; Margaret Hellard; Rebecca J Guy; Basil Donovan Journal: BMC Health Serv Res Date: 2014-07-01 Impact factor: 2.655
Authors: Shelagh M Redmond; Karin Alexander-Kisslig; Sarah C Woodhall; Ingrid V F van den Broek; Jan van Bergen; Helen Ward; Anneli Uusküla; Björn Herrmann; Berit Andersen; Hannelore M Götz; Otilia Sfetcu; Nicola Low Journal: PLoS One Date: 2015-01-23 Impact factor: 3.240
Authors: Ben B Hui; Richard T Gray; David P Wilson; James S Ward; Anthony M A Smith; David J Philip; Matthew G Law; Jane S Hocking; David G Regan Journal: BMC Infect Dis Date: 2013-04-25 Impact factor: 3.090
Authors: Dyani Lewis; Danielle C Newton; Rebecca J Guy; Hammad Ali; Marcus Y Chen; Christopher K Fairley; Jane S Hocking Journal: BMC Infect Dis Date: 2012-05-14 Impact factor: 3.090
Authors: Rebecca J Guy; Lisa Natoli; James Ward; Louise Causer; Belinda Hengel; David Whiley; Sepehr N Tabrizi; Basil Donovan; Christopher K Fairley; Steven B Badman; Annie Tangey; Handan Wand; Mark Shephard; David G Regan; David Wilson; David Anderson; John M Kaldor Journal: BMC Infect Dis Date: 2013-10-18 Impact factor: 3.090
Authors: Lloyd Einsiedel; Richard J Woodman; Maria Flynn; Kim Wilson; Olivier Cassar; Antoine Gessain Journal: BMC Public Health Date: 2016-08-15 Impact factor: 3.295